AGP
ABBV icon

Autumn Glory Partners’s AbbVie ABBV Stock Holding History

Autumn Glory Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
10,875
-464
-4% -$99.8K 0.78% 35
2026
Q1 		$2.47M Buy
11,339
+1,090
+11% +$242K 0.91% 27
2025
Q4 		$2.34M Buy
10,249
+656
+7% +$149K 0.82% 35
2025
Q3 		$2.22M Buy
9,593
+451
+5% +$91.8K 0.91% 29
2025
Q2 		$1.7M Sell
9,142
-24
-0.3% -$4.46K 0.79% 34
2025
Q1 		$1.92M Hold
9,166
– – 0.95% 31
2024
Q4 		$1.63M Sell
9,166
-3,322
-27% -$611K 0.8% 38
2024
Q3 		$2.47M Buy
12,488
+2,903
+30% +$542K 0.95% 30
2024
Q2 		$1.64M Buy
9,585
+620
+7% +$103K 0.84% 36
2024
Q1 		$1.63M Sell
8,965
-945
-10% -$163K 0.8% 37
2023
Q4 		$1.59M Buy
9,910
+50
+0.5% +$7.29K 0.9% 37
2023
Q3 		$1.47M Sell
9,860
-83
-0.8% -$12.2K 0.9% 37
2023
Q2 		$1.34M Buy
9,943
+3,549
+56% +$520K 0.98% 35
2023
Q1 		$1.02M Sell
6,394
-25,359
-80% -$3.88M 0.87% 34
2022
Q4 		$5.13M Buy
31,753
+18,843
+146% +$2.89M 2.74% 5
2022
Q3 		$1.73M Sell
12,910
-3,096
-19% -$444K 1.17% 27
2022
Q2 		$2.45M Buy
16,006
+2,632
+20% +$402K 1.81% 14
2022
Q1 		$2.17M Sell
13,374
-3,915
-23% -$569K 1.26% 20
2021
Q4 		$2.34M Buy
+17,289
New +$2.04M 0.98% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Autumn Glory Partners's ABBV Position: Q2 2026 in Review

Autumn Glory Partners reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $99.8K and leaving 10,875 shares worth $2.74M. The position accounts for 0.78% of the portfolio, ranked #35.

Autumn Glory Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.13M in Q4 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Autumn Glory Partners held 10,875 shares of AbbVie worth $2.74M as of Q2 2026.
  • Autumn Glory Partners sold 464 AbbVie shares in Q2 2026, an estimated $99.8K.
  • AbbVie made up 0.78% of Autumn Glory Partners's portfolio in Q2 2026, its #35 holding.
  • Autumn Glory Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Autumn Glory Partners's AbbVie position peaked at $5.13M in Q4 2022.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.